Oncolytics Biotech (ONCY) EPS (Basic) (2009 - 2026)
Oncolytics Biotech's (ONCY) quarterly EPS (Basic) came in at -$0.08 in Q2 2026, down 65.85% year-over-year from -$0.23 in Q2 2025, and up 33.74% quarter-over-quarter from -$0.12 in Q3 2025.
Powered by 
Analysis
Oncolytics Biotech (ONCY) EPS (Basic) (2009 - 2026) Analysis & Trends
Oncolytics Biotech (ONCY) has reported EPS (Basic) for 18 consecutive years, with -$0.08 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 65.85% year-over-year to -$0.08 in Q2 2026; TTM through Jun 2026 was -$0.25, a 3.85% decrease from a year earlier, with the FY2025 full-year figure at -$0.3, changed 0.11% from the prior year.
- EPS (Basic) was -$0.08 for Q2 2026 at Oncolytics Biotech, up from -$0.12 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.04 in Q4 2023 and troughed at -$0.13 in Q3 2023.
- A 5-year average of -$0.09 and a median of -$0.09 in 2023 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 60.84% in 2023, down 101.9% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.11 in 2022, then surged by 60.84% to -$0.04 in 2023, then sank by 77.8% to -$0.07 in 2024, then slumped by 59.52% to -$0.12 in 2025, then surged by 33.74% to -$0.08 in 2026.
- The last three EPS (Basic) figures came in at -$0.08 (Q2 2026), -$0.12 (Q3 2025), and -$0.05 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.46 Bn | 192.47 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.92 Bn | 176.75 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.37 Bn | 123.51 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.86 Bn | 73.87 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.29 Bn | 55.10 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.76 Bn | 48.62 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.16 Bn | 29.85 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.13 Bn | 29.13 Bn | 1.16 Mn | -0.40 |
| 10 | Oncolytics Biotech | 93.43 Mn | 93.43 Mn | - | -0.08 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.05 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.08 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | -0.13 |
| Jun 30, 2023 | -0.09 |
| Dec 31, 2022 | -0.11 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.10 |
| Dec 31, 2021 | -0.11 |
| Sep 30, 2021 | -0.10 |
| Jun 30, 2021 | -0.15 |
| Dec 31, 2020 | -0.18 |
| Sep 30, 2020 | -0.23 |
| Jun 30, 2020 | -0.22 |
| Mar 31, 2020 | 0.02 |
| Sep 30, 2019 | -0.22 |